X0607 3 2026-03-24 0 0001770121 Sana Biotechnology, Inc. SANA 0002115339 PATEL DHAVALKUMAR DHIRAJLAL false C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 350 SEATTLE WA 98102 false true false false EVP, Chief Scientific Officer Common Stock 99510.00 D Stock Option (Right to Buy) 5.84 2034-08-25 Common Stock 515000.00 D Stock Option (Right to Buy) 2.55 2035-03-05 Common Stock 375000.00 D Stock Option (Right to Buy) 3.41 2036-03-04 Common Stock 506250.00 D Restricted Stock Units Common Stock 375000.00 D Restricted Stock Units Common Stock 62500.00 D Restricted Stock Units Common Stock 112500.00 D The option vested as to 25% of the shares underlying the option on August 26, 2025 and the remainder vests in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana Biotechnology, Inc. ("Sana") as an employee, consultant, director or officer of Sana through each such date. The option vested as to 25% of the shares underlying the option on March 6, 2026 and the remainder vests in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The option vests and becomes exercisable as to 25% of the underlying shares on March 5, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. Each restricted stock unit represents a contingent right to receive one share of Sana common stock. The award vested as to 25% of the restricted stock units on August 26, 2025 and the remaining restricted stock units will vest in three equal installments on each of August 26, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The award vested as to 25% of the restricted stock units on March 6, 2026 and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date. /s/ Aaron M. Grossman, Attorney-in-Fact for Dhavalkumar Dhirajlal Patel 2026-03-27